⏳ Fetching live dividend data...
Home › Calculator › ANPCY Dividend Calculator 2026
CelLBxHealth plc · OTC
Price: $0.07 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ANPCY → $149954.39M in 10 years · $844,023,378.20/month
Headquartered in Guildford, United Kingdom, and established in 1994, CelLBxHealth plc (formerly known as ANGLE plc until October 2025) is a medical diagnostics company dedicated to advancing cancer detection. The firm's reach extends globally, with operations in the UK, Europe, and North America. CelLBxHealth's product portfolio features innovative medical devices such as the Parsortix PC1 system, specifically engineered to isolate and collect intact circulating tumor cells (CTCs) from the blood of metastatic breast cancer patients for subsequent user-validated analysis. They also offer the Parsortix PR1 system for general CTC capture. Further enhancing their diagnostic capabilities are the Portrait+ CTC Staining kit, a ready-to-use laboratory tool providing high analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs, alongside the CellKeep Slide for efficient CTC harvesting. In addition to its product line, the company provides comprehensive laboratory services, including CTC enrichment and liquid biopsy analysis. Their specialized assays encompass Portrait Flex, an immunofluorescence test for identifying epithelial, mesenchymal, and epithelial-to-mesenchymal transition (EMT) cells, as well as assessing DNA damage response. They also offer Portrait PD-L1 for evaluating CTCs and develop bespoke CTC assays. Strategic alliances are a key component of their development strategy, including a partnership with BioView Ltd to create a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. to leverage a pan-cancer next-generation sequencing (NGS) panel.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ANPCY position with:
Real after-tax yield depends on where you live and how you hold ANPCY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2985.07% | 2982.27% | $298,507 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2537.31% | 2534.51% | $253,731 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2388.06% | 2385.26% | $238,806 / yr |
| 🇬🇧 UK ISA | 0% | 2985.07% | 2982.27% | $298,507 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2723.88% | 2721.08% | $272,388 / yr |
| 🇨🇦 TFSA | 0% | 2985.07% | 2982.27% | $298,507 / yr |
| 🇨🇦 CA Taxable | 25% | 2238.80% | 2236.00% | $223,880 / yr |
| 🇦🇺 Super (pension) | 15% | 2537.31% | 2534.51% | $253,731 / yr |
| 🇦🇺 AU Taxable | 30% | 2089.55% | 2086.75% | $208,955 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2197.76% | 2194.96% | $219,776 / yr |
| 🇫🇷 FR Taxable | 30% | 2089.55% | 2086.75% | $208,955 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ANPCY pays quarterly — 4 times per year. Next ex-div: TBD.
How ANPCY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ANPCY sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ANPCY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CelLBxHealth plc (ANPCY) is currently trading at $0.07, trading near its 52-week low. The current dividend yield is 2985.07% based on an annual payout of $2.00 per share.
CelLBxHealth plc (ANPCY) is a healthcare stock currently trading at $0.07 with a dividend yield of 2985.07%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever